Stay updated on AK104 in NSCLC Phase II Clinical Trial

Sign up to get notified when there's something new on the AK104 in NSCLC Phase II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK104 in NSCLC Phase II Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Version bump to v3.2.0 accompanied by a government-operating-status notice; replaces v3.1.0.
    Difference
    13%
    Check dated 2025-10-06T05:34:57.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-29T03:05:37.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2 and the Back to Top element was removed. No core content, pricing, stock, or time-slot information is affected.
    Difference
    0.8%
    Check dated 2025-09-14T18:57:29.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.8%
    Check dated 2025-09-07T13:55:00.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location details, while removing specific state, country, and city information.
    Difference
    8%
    Check dated 2025-08-31T11:37:06.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.3%
    Check dated 2025-08-17T01:42:36.000Z thumbnail image

Stay in the know with updates to AK104 in NSCLC Phase II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK104 in NSCLC Phase II Clinical Trial page.